CMPMedica signs global contract with iSOFT for drug information
decision support tools
9 January 2009
CMPMedica, a division of United Business Media Limited, has signed a
worldwide agreement to supply healthcare IT systems supplier iSOFT with
comprehensive evidence-based drug information. CMPMedica's information
solution will power iSOFT's suite of decision-support tools. These tools
enable healthcare professionals to make better informed decisions at the
point of care and thus improve patient outcomes.
CMPMedica has supplied iSOFT with drug information systems for over
40 years and this extended relationship is a testament to how well the
two companies have worked together to develop their respective
businesses in Australia and Asia. Both companies are looking to expand
their relationship into new territories around the world as demand for
evidence-based decision support tools continues to grow.
Healthcare providers increasingly recognise the need for
comprehensive, up to date information to support the treatment decisions
of their healthcare professionals.
Henry Elkington, CEO of CMPMedica said: "The award of this contract
demonstrates that we are addressing the needs of one of the most dynamic
multi-national healthcare solution providers. By providing trusted local
data with best-in-class decision support tools we are enabling solutions
that will be recognised and welcomed by clinicians. In addition, by
delivering data through a common interface we can speed up and simplify
deployment for the solution provider."
"We are delighted to be able to build on our existing relationship
with iSOFT and look forward to supporting the growth and development of
their business around the world."
Dr Michael Dahlweid, iSOFT's Chief Medical Officer said: "The
agreement with CMPMedica will provide improved and real-time access to
CMPMedica's sophisticated knowledgebases. When interacting with iSOFT
products, these decision-support tools will provide the capacity to
alert clinicians to interactions between medicines, food, health
conditions and patient allergies and more, making patient safety the
priority in a world of increasing drug complexity."
"This new service will strengthen the quality of the drug content
available within iSOFT products giving our customers ready access to the
very latest drug and allergy information ensuring that prescribing
clinicians have up-to-date and fully integrated drug information to
enhance patient treatment and safety."
Bookmark this page